Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fredric P Manfredsson

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2009
AAV9: a potential blood-brain barrier busterFredric P Manfredsson, Aaron C Rising, Ronald J Mandel
Current Opinion in Neurobiology|December 20, 2025
Gene therapy for Parkinson's disease-Ample room for optimismIvette M Sandoval, Michael F Salvatore, Fredric P Manfredsson
Annals of Neurology|October 7, 2017
Can STN DBS protect both nigral somata and innervation of the striatum?D Luke Fischer, Fredric P Manfredsson, Caryl E Sortwell
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2019
Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome EditingIvette M Sandoval, Timothy J Collier, Fredric P Manfredsson
JAMA Neurology|June 19, 2018
Challenges in Passive Immunization Strategies to Treat Parkinson DiseaseFredric P Manfredsson, Malú G Tansey, Todd E Golde
Neurobiology of Disease|March 20, 2012
Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issuesFredric P Manfredsson, David C Bloom, Ronald J Mandel
Handbook of Experimental Pharmacology|January 2, 2023
The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's DiseaseMargaret E Caulfield, Fredric P Manfredsson, Kathy Steece-Collier
Journal of Neurochemistry|February 8, 2016
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseMatthew J Benskey, Ruth G Perez, Fredric P Manfredsson
Current Gene Therapy|October 29, 2009
Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson's diseaseFredric P Manfredsson, Michael S Okun, Ronald J Mandel
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2007
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the ratSharon Reimsnider, Fredric P Manfredsson, Nicholas Muzyczka, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 28, 2009
AAV9: a potential blood-brain barrier busterFredric P Manfredsson, Aaron C Rising, Ronald J Mandel
Current Opinion in Neurobiology|December 20, 2025
Gene therapy for Parkinson's disease-Ample room for optimismIvette M Sandoval, Michael F Salvatore, Fredric P Manfredsson
Annals of Neurology|October 7, 2017
Can STN DBS protect both nigral somata and innervation of the striatum?D Luke Fischer, Fredric P Manfredsson, Caryl E Sortwell
Methods in Molecular Biology (Clifton, N.J.)|February 2, 2019
Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome EditingIvette M Sandoval, Timothy J Collier, Fredric P Manfredsson
JAMA Neurology|June 19, 2018
Challenges in Passive Immunization Strategies to Treat Parkinson DiseaseFredric P Manfredsson, Malú G Tansey, Todd E Golde
Neurobiology of Disease|March 20, 2012
Regulated protein expression for in vivo gene therapy for neurological disorders: progress, strategies, and issuesFredric P Manfredsson, David C Bloom, Ronald J Mandel
Handbook of Experimental Pharmacology|January 2, 2023
The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's DiseaseMargaret E Caulfield, Fredric P Manfredsson, Kathy Steece-Collier
Journal of Neurochemistry|February 8, 2016
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's diseaseMatthew J Benskey, Ruth G Perez, Fredric P Manfredsson
Current Gene Therapy|October 29, 2009
Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson's diseaseFredric P Manfredsson, Michael S Okun, Ronald J Mandel
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 15, 2007
Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the ratSharon Reimsnider, Fredric P Manfredsson, Nicholas Muzyczka, et al.
Pageof 12